Dr Mike Strange

Head of Operations, Diseases of the Developing World,

GSK

Dr Mike Strange is Head of Operations at the Tres Cantos Medicines Development Campus, GSK’s specialist research campus dedicated to the discovery of new medicines for diseases of the developing world where over 120 scientific staff work in a range of specialisms including chemistry, biology, biochemistry, toxicology, assay development, and in vivo and in vitro and high through-put screening.

Mike has more than 10 years’ experience within GSK working in a variety of strategic and operational roles in Pharmaceutical R&D and has also spent 3 years as Head of Business Operations within Global Clinical Development at GSK Vaccines in Belgium. In his current role, Mike has spearheaded the set up of GSK’s open innovation approach at Tres Cantos including the set up of GSK’s open lab and the Tres Cantos Open Lab Foundation.

Mike has a BSc (Hons) in Mathematics, an MSc in Mathematics and Biology and a PhD in Applied Mathematics from the University of Hull and an MBA from London Business School.